Top Clinical Trials companies in Sweden by Dividends Paid

This ranking features the top 15 Clinical Trials companies in Sweden ranked by Dividends Paid, totalling a Dividends Paid of USD 0.00, for January 15, 2025.
#
Name
Dividends Paid
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 0.00
Dec. 31, 2023 USD 0.11 1.51%

Sweden

2
USD 0.00
Dec. 31, 2023 USD 2.74 1.67%

Sweden

3
USD 0.00
Dec. 31, 2023 USD 17.87 3.09%

Sweden

4
USD 0.00
Dec. 31, 2023 USD 0.84 -0.17%

Sweden

5
USD 0.00
Dec. 31, 2023 USD 0.28 -7.61%

Sweden

6
USD 0.00
Dec. 31, 2023 USD 0.21 0.68%

Sweden

7
USD 0.00
Aug. 31, 2024 USD 1.61 0.34%

Sweden

8
USD 0.00
Dec. 31, 2023 USD 2.91 -2.20%

Sweden

9
USD 0.00
Dec. 31, 2023 USD 0.71 -2.02%

Sweden

10
USD 0.00
Dec. 31, 2023 USD 0.90 9.88%

Sweden

11
USD 0.00
Dec. 31, 2023 USD 0.20 1.12%

Sweden

12
USD 0.00
Dec. 31, 2023 USD 1.17 -3.73%

Sweden

13
USD 0.00
Aug. 31, 2024 USD 0.22 -6.29%

Sweden

14
USD 0.00
Dec. 31, 2023 USD 0.39 2.53%

Sweden

15
USD 0.00
Dec. 31, 2023 USD 0.80 0.68%

Sweden

Frequently Asked Questions
  • Which Clinical Trials company in Sweden has the highest Dividends Paid ?

    The Clinical Trials company in Sweden with the highest Dividends Paid is Aptahem AB (publ) (Stockholm Stock Exchange: APTA.ST) at USD 0.00.

  • Which Clinical Trials company in Sweden has the lowest Dividends Paid ?

    The Clinical Trials company in Sweden with the lowest Dividends Paid is Prostatype Genomics AB (publ) (Stockholm Stock Exchange: PROGEN.ST) at USD 0.00.